Structured evidence table for L-Carnitine Fatigue Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| L-Carnitine Fatigue Randomized Trial | Aging is closely associated with oxidative stress, mitochondrial dysfunction, chronic inflammation, and progressive declines in muscle and cognitive function. | 4 | Wang X (2026) | Glycine and N-acetylcysteine supplementation, with or without exercise, in brain health and functional aging: implications for sarcopenia and frailty in older adults. |
| L-Carnitine Fatigue Randomized Trial | Evidence on NAC suggests context-dependent effects, with supplementation improving glutathione availability, fatigue resistance, and exercise performance in individuals with low baseline glutathione, while results remain inconsistent in healthy populations. | 4 | Wang X (2026) | Glycine and N-acetylcysteine supplementation, with or without exercise, in brain health and functional aging: implications for sarcopenia and frailty in older adults. |
| L-Carnitine Fatigue Randomized Trial | Exercise is widely recognized as the most effective non-pharmacological strategy to counteract these processes; however, its benefits may be potentiated by targeted nutritional interventions. | 4 | Wang X (2026) | Glycine and N-acetylcysteine supplementation, with or without exercise, in brain health and functional aging: implications for sarcopenia and frailty in older adults. |
| L-Carnitine Fatigue Randomized Trial | Serotonin and norepinephrine are key mediators of pain control, and evidence indicates that dual reuptake inhibition provides superior analgesia compared to single-pathway approaches. | 4 | Lago IOD (2026) | Serotonin-Norepinephrine Reuptake Inhibitors in Fibromyalgia Management: An Integrative Literature Review of Clinical Evidence. |
| L-Carnitine Fatigue Randomized Trial | Fibromyalgia (FM) is a chronic pain syndrome characterized by central sensitization and impaired pain modulation, involving dysfunctional descending inhibitory pathways and altered nociceptive processing. | 4 | Lago IOD (2026) | Serotonin-Norepinephrine Reuptake Inhibitors in Fibromyalgia Management: An Integrative Literature Review of Clinical Evidence. |
| L-Carnitine Fatigue Randomized Trial | These processes contribute to persistent musculoskeletal pain, difficulties with sleep, feelings of depression, and ongoing fatigue. | 4 | Lago IOD (2026) | Serotonin-Norepinephrine Reuptake Inhibitors in Fibromyalgia Management: An Integrative Literature Review of Clinical Evidence. |
Source documents